Vaccine cuts meningitis rates, even in adults
By Julie Steenhuysen
CHICAGO (Reuters) - A routine childhood vaccine used to prevent several common types of infections has helped cut the rate of a deadly form of meningitis by 30 percent in children and adults, U.S. researchers said on Wednesday, suggesting even the unvaccinated are benefiting from the shot.
They said the vaccine Prevnar made by Wyeth significantly reduced cases of meningitis caused by pneumococcal bacteria strains covered by the vaccine.
But they also noted a worrisome increase of pneumococcal meningitis in strains not covered by the vaccine and those that resist antibiotics.
“When you immunize children, they are much less likely to carry pneumococcal strains covered by the vaccine in the back of the throat,” Dr. Lee Harrison of the University of Pittsburgh School of Medicine, whose study appears in the New England Journal of Medicine, said in a statement.
“When vaccinated children don’t carry these virulent strains, they don’t end up transmitting them to other children, their parents and grandparents.”
Harrison said the study clearly shows adults not covered by the vaccine benefit, suggesting it conveys so-called “herd immunity” to people who have not been vaccinated. Previous studies showed it protected elderly people against deadly pneumonia strains, even when they were not given an adult vaccine.
Data has previously been mixed on whether Prevnar was reducing meningitis infections in adults.
“That is why we did the study,” Harrison said in a telephone interview. “It was a huge question because the death rate from pneumococcal meningitis is over 20 percent.”
Harrison’s team reviewed cases of pneumococcal meningitis from 1998 through 2005. They found disease rates fell 64 percent in children under 2 and 54 percent in older adults after the 2000 introduction of Prevnar, also known as Prevenar, pediatric pneumococcal conjugate vaccine or PCV7.
Prevnar protects against seven of the most common strains of Streptococcus pneumoniae, known commonly as pneumococcal bacteria. These germs account for more than 80 percent of pneumococcal disease in children, causing ear infections, meningitis, pneumonia and blood infections.
Harrison said non-PCV7 strains of meningitis increased by 60.5 percent from 1998-99 to 2004-2005. They also found the percentage of strains not sensitive to penicillin rose to 30.1 percent in 2005, from 19.4 percent in 2003. “The fact that these strains are increasing is obviously worrisome,” he said.
Harrison said the vaccine has been highly successful in preventing bacterial meningitis, but it remains deadly.
“We do need new vaccines that will cover additional strains not included in the current vaccine,” he said.
Wyeth is testing an expanded version of the vaccine that will cover 13 strains of pneumococcal bacteria and has said it plans to seek U.S. regulatory approval in the first quarter of this year.
Harrison said he evaluated the new Wyeth vaccine and based on currently available data, he thinks it will cover about half of the remaining disease.
(Editing by Maggie Fox)
--------------------------------------------------------------------------------------------Related Posts:
WASHINGTON (Reuters) - Smokers should be vaccinated against a pneumonia-causing germ, along with children and the elderly, U.S. federal advisers recommended on Wednesday. If accepted by the Centers for Disease Control and Prevention, it would be the first vaccine recommendation aimed specifically at smokers. The vaccines, called pneumococcal vaccines, prevent infection with several strains of Streptococcus pneumonia,
Full Post: Smokers should get pneumonia vaccine: U.S. advisers
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - People with asthma are at increased risk of serious infection with pneumococcal bacteria, according to a new analysis of medical records. The findings, along with the high fatality rate from such infections, suggest that adults with asthma would benefit from the pneumococcal vaccine, Dr. Young J. Juhn of the Mayo Clinic
Full Post: Asthma may boost pneumococcal infection risk
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - U.S. health officials asked doctors on Thursday to be alert for possible cases of meningitis and other illnesses in children caused by Hib bacteria amid an ongoing vaccine shortage. Officials are most concerned about bacterial meningitis and sepsis, a bloodstream infection, caused by Hib (Haemophilus influenzae type b) in children under
Full Post: Doctors to be on guard for meningitis in kids
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - A quarter of girls aged 13-17 in the United States received Merck & Co’s Gardasil vaccine last year to protect against the human papillomavirus, which causes cervical cancer, the U.S. government said on Thursday. A report by the Centers for Disease Control and Prevention provided the first look at how many
Full Post: Quarter of adolescent U.S. girls received HPV vaccine
--------------------------------------------------------------------------------------------
LONDON (Reuters) - Giving just one fifth the dose of a commonly used meningitis vaccine may be as effective as using the full dose, researchers said on Tuesday. The finding should allow medics to stretch scarce vaccine resources, especially during epidemics in Africa. A clinical study conducted in Uganda by Epicentre — the research arm of medical
Full Post: Partial vaccine dose may work as well as full shot